Don Soffer Clinical Research Center 730 (D48)
Donna Lundy, Ph.D.
- Division Chief, Speech Pathology
Dr. Lundy is a Principal Investigator of an internal grant evaluating the manner of prophylactic swallowing therapy delivery (face-to-face vs. home assignment) in patients undergoing definitive chemo-radiation for oropharyngeal cancer. She is a co-investigator in projects looking at swallowing outcomes following transoral robotic surgery (TORS) for oropharyngeal cancer. Dr. Lundy also has ongoing research evaluating the efficacy of different voice prostheses for individuals following total laryngectomy.